125 related articles for article (PubMed ID: 29395091)
1. Assessment of biotin interference with qualitative point-of-care hCG test devices.
Williams GR; Cervinski MA; Nerenz RD
Clin Biochem; 2018 Mar; 53():168-170. PubMed ID: 29395091
[TBL] [Abstract][Full Text] [Related]
2. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
Milhorn D; Korpi-Steiner N
Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
[TBL] [Abstract][Full Text] [Related]
3. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
Nerenz RD; Song H; Gronowski AM
Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
[TBL] [Abstract][Full Text] [Related]
4. Limitations in qualitative point of care hCG tests for detecting early pregnancy.
Greene DN; Schmidt RL; Kamer SM; Grenache DG; Hoke C; Lorey TS
Clin Chim Acta; 2013 Jan; 415():317-21. PubMed ID: 23159297
[TBL] [Abstract][Full Text] [Related]
5. Analytical sensitivity of four commonly used hCG point of care devices.
Kamer SM; Foley KF; Schmidt RL; Greene DN
Clin Biochem; 2015 Apr; 48(6):448-52. PubMed ID: 25549977
[TBL] [Abstract][Full Text] [Related]
6. Biotin as a masking agent in chorionic gonadotropin assays utilizing biotinylated antibodies.
Sobolevsky T; Ahrens B
Drug Test Anal; 2021 Nov; 13(11-12):1929-1935. PubMed ID: 34378342
[TBL] [Abstract][Full Text] [Related]
7. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy.
Cervinski MA; Lockwood CM; Ferguson AM; Odem RR; Stenman UH; Alfthan H; Grenache DG; Gronowski AM
Clin Chim Acta; 2009 Aug; 406(1-2):81-5. PubMed ID: 19477170
[TBL] [Abstract][Full Text] [Related]
8. Impact of Biotin Supplementation on Human Chorionic Gonadotropin Immunoassays Utilizing Biotin-Streptavidin Binding Methods in Urine.
Goodrum JM; Nair VS; Moore C; Crouch AK; Eichner D; Miller GD
Clin Chem; 2023 Jul; 69(7):754-762. PubMed ID: 37253044
[TBL] [Abstract][Full Text] [Related]
9. Performance of qualitative urinary hCG assays.
Nickmans S; Vermeersch P; Van Eldere J; Billen J
Acta Clin Belg; 2014 Aug; 69(4):277-9. PubMed ID: 24846178
[TBL] [Abstract][Full Text] [Related]
10. Heterophile antibody interference in qualitative urine/serum hCG devices: Case report.
Patel KK; Gronowski AM
Clin Biochem; 2016 Jun; 49(9):729-731. PubMed ID: 26968106
[TBL] [Abstract][Full Text] [Related]
11. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.
Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM
Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816
[TBL] [Abstract][Full Text] [Related]
13. Significance of pregnancy test false negative results due to elevated levels of β-core fragment hCG.
Johnson S; Eapen S; Smith P; Warren G; Zinaman M
J Immunoassay Immunochem; 2017; 38(4):449-455. PubMed ID: 28521601
[TBL] [Abstract][Full Text] [Related]
14. Estimating the hCGβcf in urine during pregnancy.
Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
[TBL] [Abstract][Full Text] [Related]
15. Urinary Tract Infection With Gram-Positive Bacteria Does Not Cause False-Positive Results with the Urine-Based Human Chorionic Gonadotropic Point-of-Care Assay.
Mitchell KF; Burnham CD; Gronowski AM
J Appl Lab Med; 2020 Sep; 5(5):987-992. PubMed ID: 32761095
[TBL] [Abstract][Full Text] [Related]
16. Characterizing urinary hCGβcf patterns during pregnancy.
Nerenz RD; Yarbrough ML; Stenman UH; Gronowski AM
Clin Biochem; 2016 Jul; 49(10-11):777-81. PubMed ID: 27087510
[TBL] [Abstract][Full Text] [Related]
17. A case of consistent discrepancies between urine and blood human chorionic gonadotropin measurements.
Albersen A; Kemper-Proper E; Thelen MH; Kianmanesh Rad NA; Hoedemaeker RF; Boesten LS
Clin Chem Lab Med; 2011 Jun; 49(6):1029-32. PubMed ID: 21410410
[TBL] [Abstract][Full Text] [Related]
18. A device architecture for three-dimensional, patterned paper immunoassays.
Schonhorn JE; Fernandes SC; Rajaratnam A; Deraney RN; Rolland JP; Mace CR
Lab Chip; 2014 Dec; 14(24):4653-8. PubMed ID: 25300302
[TBL] [Abstract][Full Text] [Related]
19. Urinary human chorionic gonadotropin isoform concentrations in doping control samples.
Butch AW; Woldemariam GA
Drug Test Anal; 2016 Nov; 8(11-12):1147-1151. PubMed ID: 27594536
[TBL] [Abstract][Full Text] [Related]
20. Negative urine pregnancy test in a molar pregnancy: is it possible?
Nigam A; Kumari A; Gupta N
BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25378114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
